Fine-Tuning Clot-Busting Treatment For Bleeding In Brain Dramatically Increases Survival

A multicenter study led by Johns Hopkins doctors has fine-tuned the dosage and timing for administering clot-busting tissue plasminogen activator (tPA) to patients with strokes caused by bleeding within the brain. The treatment, as reported this week at the European Stroke Conference in Nice, France, has been shown to dramatically decrease death and disability in patients with this typically lethal subset of stroke.

More: continued here

Filed under: Blood on May 17th, 2008